CytomX Therapeutics, Inc. (CTMX)
4.365
-0.20
(-4.28%)
USD |
NASDAQ |
Apr 02, 14:29
CytomX Therapeutics Research and Development Expense (TTM) : 67.60M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Rigel Pharmaceuticals, Inc. | 33.30M |
| REGENXBIO, Inc. | 212.68M |
| Ovid Therapeutics, Inc. | 25.38M |
| Olema Pharmaceuticals, Inc. | 157.70M |